Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.

SAN DIEGO and DUBLIN, Ohio, Aug. 12, 2013 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) ("Navidea") breached their fiduciary duties to shareholders.  Navidea focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to http://www.robbinsarroyo.com.  

Press release link: http://www.robbinsarroyo.com/shareholders-rights-blog/navidea-biopharmaceuticals-inc/

Attorney Advertising. Past results do not guarantee a similar outcome.   

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

SOURCE Robbins Arroyo LLP